Study on the Mechanism of Jiedu Sanjie Formula in the Treatment of Gastric Cancer Based on Network Pharmacology and Molecular Docking
Journal of Experimental and Clinical Application of Chinese Medicine · 10.06.2026 · 35-50
DOI: 10.62767/jecacm702.1579 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental and Clinical Application of Chinese Medicine, online erschienen am 10.06.2026. Verfasst von Yixin Fu und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to investigate the potential active ingredients, core targets and molecular mechanisms of Jiedu Sanjie Formula in the treatment of gastric cancer, thereby providing a theoretical basis for its clinical application and experimental research.
Methods
The effective ingredients and corresponding targets of Jiedu Sanjie Formula were screened using TCMSP, TCMID and HERB databases, as well as network resources, including GeenMedical and Chinese literature. Gastric cancer-related targets were retrieved from DrugBank, OMIM, TTD and GeneCards databases. With STRING platform, the protein-protein interaction network was established, from which core targets were identified. GO functional enrichment and KEGG pathway enrichment analyses were performed using the DAVID database, and the pathway-target network diagram was visualized with Gephi 0.9.2. Finally, molecular docking was conducted with AutoDock Tool-1.5.7, and the results were visualized by PyMOL software.
Results
A total of 38 active ingredients were identified in Jiedu Sanjie Formula, corresponding to 859 drug-related targets, among which 497 overlapped with gastric cancer targets. The main active ingredients included quercetin, stigmasterol, cinobufagin, and cinobufotalin. Mechanistically, the formula exerted anti-gastric cancer effects by acting on core targets such as AKT1, AKT3, MAP2K1, PIK3R1 and PIK3CD, thereby regulating tumor-related signaling pathways including the PI3K-Akt pathway, HIF-1 pathway and cancer-related pathways. Molecular docking results confirmed good binding affinity between core active ingredients and key targets.
Conclusion
Based on network pharmacology prediction, Jiedu Sanjie Formula can synergistically mediate the pathological processes such as proliferation and apoptosis of gastric cancer cells through multi-component, multi-target and multi-pathway modes. Its anti-gastric cancer mechanism is closely related to the regulation of classical tumor signaling pathways, providing theoretical support for subsequent basic experimental validation and clinical translation.
Zitieren
APA
Fu, Y., Zhou, L., Huang, J., Xiong, R., & Fu, Y. (2026). Study on the Mechanism of Jiedu Sanjie Formula in the Treatment of Gastric Cancer Based on Network Pharmacology and Molecular Docking. Journal of Experimental and Clinical Application of Chinese Medicine, 35-50. https://doi.org/10.62767/jecacm702.1579
Vancouver
Fu Y, Zhou L, Huang J, Xiong R, Fu Y. Study on the Mechanism of Jiedu Sanjie Formula in the Treatment of Gastric Cancer Based on Network Pharmacology and Molecular Docking. Journal of Experimental and Clinical Application of Chinese Medicine. 2026:35-50. doi:10.62767/jecacm702.1579
BibTeX
@article{Fu2026,
author = {Fu, Yixin and Zhou, Longjian and Huang, Jing'er and Xiong, Ruihua and Fu, Yanli},
title = {Study on the Mechanism of Jiedu Sanjie Formula in the Treatment of Gastric Cancer Based on Network Pharmacology and Molecular Docking},
journal = {Journal of Experimental and Clinical Application of Chinese Medicine},
year = {2026},
pages = {35--50},
doi = {10.62767/jecacm702.1579}
}
EUVIMED